Nuzenio

Scisparc

Scisparc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Scisparc Ltd (SPRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 13:45:59 GMTSciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Thu, 06 Aug 2026 01:44:24 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 12:30:00 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTPrice to book forward of SciSparc Ltd. – NASDAQ:SPRC - TradingViewTradingView · Tue, 04 Aug 2026 19:11:09 GMTSciSparc Company Profile & Introduction - MoomooMoomoo · Mon, 03 Aug 2026 01:06:01 GMT

Timeline

Fri, 07 Aug 2026 13:45:59 GMTScisparc Ltd (SPRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thu, 06 Aug 2026 01:44:24 GMTSciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance UK
Wed, 05 Aug 2026 13:00:51 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan
Wed, 05 Aug 2026 12:30:00 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver Quantitative
Wed, 05 Aug 2026 12:22:00 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswire
Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.AIAI stories cover models, chips, safety, regulation, products, jobs, research, and how automated systems are being used.CybersecurityCybersecurity stories explain incidents, vulnerabilities, affected organizations, user risk, patches, and accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Scisparc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.